Trial intelligence / Profile preview

Botox vs Placebo with Casting for Idiopathic Toe Walking

NCT00175669Phase 2Completed

Sponsor
University of British Columbia
Start
Aug 2007
Primary completion
Nov 2009
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in idiopathic toe walking (ITW), sponsored by University of British Columbia. Started Aug 2007; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

idiopathic toe walking (ITW)

Beyond the preview

Go deeper on NCT00175669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00175669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call